erenumab (aimovig) is the first of four new migraine drugs in the pipeline that target calcitonin gene-related peptide (cgrp), a molecule that's produced in nerve cells of the . . .
not coincidentally, maine has a high rate of whooping cough cases � 21.1 per 100,000 people in 2015, compared to 10.3 per 100,000 nationwide. .